The Inspire ANTI SNORING Implant is really a medical device that is implanted into the body for the treatment of snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive Sleep Apnea Syndrome
Obstructive anti snoring syndrome is a disease due to relapsing episodes of anti snoring. It is a condition where breathing stops for a lot more than 10 seconds, where oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs during sleep, once the muscles of upper airways relax, causing the obstruction of the respiratory system. This results in deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places pressure on the body, causing increased blood circulation pressure and development of severe diseases. The diseases caused by OSA can be physical, such as hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or a polysomnography is needed. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severe nature of the disease. The apnea index is known as significant if there are a lot more than 20 apnea episodes each hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many folks think it is uncomfortable to sleep with the mask on the facial skin and the machine itself can be loud, especially as it commonly sits near the head. Only 25% of patients may use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of this device is placed under the skin, on the front right side of the chest also it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stand out, and helps keep the airways open while asleep.
In addition to the two electrodes, this device also contains a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of your day, when a person needs physiological narrowing of the larynx and tongue movements for these processes.
The individual may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements usually do not cause pain, instead just a minor discomfort. These unpleasant effects disappear following the first few uses of the device.
Generally, the implant ought to be checked 1 or 2 2 times per year. However, depending on the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire ANTI SNORING Implant is only suitable for:
Patients who are more than 22 years old.
Patients who’ve been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients with an apnea index in the number of 20 to 65.
Patients who are not comfortable with using CPAP therapy or didn’t work.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
ufabet A person with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A study by Dr. Ryan J. et al. has shown that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A percentage of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at two years after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly use of this therapy for five years. Therefore, it is evident that method is impressive and simple to use!